Rheb1-mTORC1 maintains macrophage differentiation and phagocytosis in mice

Ras homolog enriched in brain (Rheb1) is a small GTPase and is known to be a direct activator of mTORC1. Dysregulation of Rheb1 has been shown to impair the cellular-energetic state and cell homeostasis. However, the role of Rheb1 in monocytes/macrophages differentiation and maturation is not clear....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental cell research 2016-06, Vol.344 (2), p.219-228
Hauptverfasser: Wang, Xiaomin, Li, Minghao, Gao, Yanan, Gao, Juan, Yang, Wanzhu, Liang, Haoyue, Ji, Qing, Li, Yanxin, Liu, Hanzhi, Huang, Jian, Cheng, Tao, Yuan, Weiping
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Ras homolog enriched in brain (Rheb1) is a small GTPase and is known to be a direct activator of mTORC1. Dysregulation of Rheb1 has been shown to impair the cellular-energetic state and cell homeostasis. However, the role of Rheb1 in monocytes/macrophages differentiation and maturation is not clear. Here, we investigate the role of Rheb1 in mouse myelopoiesis using a Rheb1 conditional deletion murine model. We found that the absolute number of macrophages decreased in the bone marrow (BM) of Rheb1-deficient mice. Loss of Rheb1 inhibited the monocyte-to-macrophage differentiation process. Additionally, Rheb1 deletion reduced phagocytosis ability of macrophages by inhibiting the mTORC1 signaling pathway. Furthermore, 3BDO (an activator of mTORC1) rescued the phagocytosis ability of Rheb1-deficient macrophages. Thus, Rheb1 is critical for macrophage production and phagocytosis and executes these activities possibly via mTORC1-dependent pathway. [Display omitted] •Rheb1 deletion impaired myeloid development in fetal liver and adult bone marrow.•Rheb1 deletion inhibited the monocyte-to-macrophage differentiation process.•Rheb1 deletion reduced phagocytosis of macrophages by decreasing mTORC1 activity.
ISSN:0014-4827
1090-2422
DOI:10.1016/j.yexcr.2016.04.017